Keystone eSymposia Logo

Precision Oncology: Translating Discovery to the Clinic

June 21-24, 2021 | 9:00AM EDT | 1:00PM UTC | 3:00PM CEST*
*Program is in development and subject to change


Reset

Advanced Filters
09:00am - 09:40am EDT - June 21, 2021
Klaus P. Hoeflich, PhD, Chair, Nested Bio
Track: Welcoming Remarks and Keynote Address

Monday
09:00am - 09:40am EDT - June 21, 2021
Charles L. Sawyers, MD, Johns Hopkins University School of Medicine
Track: Welcoming Remarks and Keynote Address

09:40am - 10:55am EDT - June 21, 2021
Scott W. Lowe, PhD, Co-Chair, Memorial Sloan Kettering Cancer Center; Todd R. Golub, MD, Co-Chair, Broad Institute
Track: Clinical Genomics

Monday
09:40am - 10:05am EDT - June 21, 2021
Todd R. Golub, MD, Broad Institute
Track: Clinical Genomics

Monday
10:05am - 10:30am EDT - June 21, 2021
Elli Papaemmanuil, PhD, Memorial Sloan Kettering Cancer Center
Track: Clinical Genomics

Monday
10:30am - 10:55am EDT - June 21, 2021
Jaclyn A. Biegel, PhD, Children's Hospital Los Angeles and Keck School of Medicine of USC
Track: Clinical Genomics

11:15am - 01:00pm EDT - June 21, 2021
Todd R. Golub, MD, Co-Chair, Broad Institute; Scott W. Lowe, PhD, Co-Chair, Memorial Sloan Kettering Cancer Center
Track: Targeting Novel Mechanisms

Monday
11:15am - 11:40am EDT - June 21, 2021
John V. Heymach, MD, PhD, University of Texas MD Anderson Cancer Center
Track: Targeting Novel Mechanisms

Monday
11:40am - 12:05pm EDT - June 21, 2021
Arvin C. Dar, PhD, Icahn School of Medicine at Mount Sinai
Track: Targeting Novel Mechanisms

Monday
12:05pm - 12:30pm EDT - June 21, 2021
Scott W. Lowe, PhD, Memorial Sloan Kettering Cancer Center
Track: Targeting Novel Mechanisms

Monday
12:45pm - 01:00pm EDT - June 21, 2021
Triparna Sen, PhD, Memorial Sloan Kettering Cancer Center
Track: Targeting Novel Mechanisms

09:00am - 11:10am EDT - June 22, 2021
Alice T. Shaw, MD, PhD, Co-Chair, Novartis Institutes for Biomedical Research, Inc.; Nicola Aceto, PhD, Co-Chair, ETH Zürich
Track: Emerging Technologies I

Tuesday
09:00am - 09:25am EDT - June 22, 2021
Valsamo Anagnostou, MD, Johns Hopkins University School of Medicine
Track: Emerging Technologies I

Tuesday
09:25am - 09:50am EDT - June 22, 2021
Gromoslaw A. Smolen, PhD, Celsius Therapeutics
Track: Emerging Technologies I

Tuesday
09:50am - 10:15am EDT - June 22, 2021
Nicola Aceto, PhD, ETH Zürich
Track: Emerging Technologies I

Tuesday
10:15am - 10:40am EDT - June 22, 2021
Cigall Kadoch, PhD, Dana-Farber Cancer Institute, Harvard Medical School
Track: Emerging Technologies I

Tuesday
10:40am - 10:55am EDT - June 22, 2021
Ramya Sridharan, BS, Weill Cornell Medical
Track: Emerging Technologies I

Tuesday
10:55am - 11:10am EDT - June 22, 2021
Xin Jin, BS, Broad Institute of MIT and Harvard
Track: Emerging Technologies I

11:20am - 01:00pm EDT - June 22, 2021
Nicola Aceto, PhD, Co-Chair, ETH Zürich; Alice T. Shaw, MD, PhD, Co-Chair, Novartis Institutes for Biomedical Research, Inc.
Track: Clinical Trials and Overcoming Resistance

Tuesday
11:20am - 11:45am EDT - June 22, 2021
Alice T. Shaw, MD, PhD, Novartis Institutes for Biomedical Research, Inc.
Track: Clinical Trials and Overcoming Resistance

Tuesday
11:45am - 12:10pm EDT - June 22, 2021
Lori Friedman, PhD, ORIC Pharmaceuticals
Track: Clinical Trials and Overcoming Resistance

Tuesday
12:10pm - 12:35pm EDT - June 22, 2021
Jessica J. Lin, MD, Massachusetts General Hospital
Track: Clinical Trials and Overcoming Resistance

Tuesday
12:35pm - 01:00pm EDT - June 22, 2021
Nikhil Wagle, MD, Dana-Farber Cancer Institute
Track: Clinical Trials and Overcoming Resistance

Tuesday
02:00pm - 03:00pm EDT - June 22, 2021
Sarah Hamilton, PhD, Cell Reports Medicine; Miguel Foronda, PhD, Nature Cancer; Avital Lev, PhD, Cancer Discovery; Lise Roth, PhD, EMBO Press
Track: Keystone Symposia Roundtables

09:00am - 10:55am EDT - June 23, 2021
Jason S. Carroll, PhD, Co-Chair, Cancer Research UK, University of Cambridge; Russell W. Jenkins, MD, PhD, Co-Chair, Massachusetts General Hospital
Track: Emerging Technologies II

Wednesday
09:00am - 09:25am EDT - June 23, 2021
Priti Hegde, PhD, Foundation Medicine
Track: Emerging Technologies II

Wednesday
09:25am - 09:50am EDT - June 23, 2021
Russell W. Jenkins, MD, PhD, Massachusetts General Hospital
Track: Emerging Technologies II

Wednesday
09:50am - 10:15am EDT - June 23, 2021
Nir Yosef, PhD, University of California, Berkeley
Track: Emerging Technologies II

Wednesday
10:15am - 10:40am EDT - June 23, 2021
Nathanael Gray, PhD, Stanford University
Track: Emerging Technologies II

Wednesday
10:40am - 10:55am EDT - June 23, 2021
Hannah Julia Uckelmann, PhD, Dana-Farber Cancer Institute
Track: Emerging Technologies II

11:10am - 01:15pm EDT - June 23, 2021
Russell W. Jenkins, MD, PhD, Co-Chair, Massachusetts General Hospital; Jason S. Carroll, PhD, Co-Chair, Cancer Research UK, University of Cambridge
Track: Targeting Gene Transcription

Wednesday
11:10am - 11:35am EDT - June 23, 2021
Christopher Vakoc, MD, PhD, Cold Spring Harbor Laboratory
Track: Targeting Gene Transcription

Wednesday
11:35am - 12:00pm EDT - June 23, 2021
Jason S. Carroll, PhD, Cancer Research UK, University of Cambridge
Track: Targeting Gene Transcription

Wednesday
12:00pm - 12:25pm EDT - June 23, 2021
Trudy G. Oliver, PhD, Huntsman Cancer Institute
Track: Targeting Gene Transcription

Wednesday
12:25pm - 12:50pm EDT - June 23, 2021
Scott A. Armstrong, MD, PhD, Dana-Farber Cancer Institute
Track: Targeting Gene Transcription

Wednesday
12:50pm - 01:15pm EDT - June 23, 2021
Timothy Heffernan, PhD, MD Anderson Cancer Center
Track: Targeting Gene Transcription

09:00am - 11:10am EDT - June 24, 2021
Scott W. Lowe, PhD, Co-Chair, Memorial Sloan Kettering Cancer Center; Klaus P. Hoeflich, PhD, Co-Chair, Nested Bio
Track: Novel Therapeutics

Thursday
09:00am - 09:25am EDT - June 24, 2021
Martin McMahon, PhD, University of Utah School of Medicine
Track: Novel Therapeutics

Thursday
09:25am - 09:50am EDT - June 24, 2021
Track: Novel Therapeutics

Thursday
09:50am - 10:15am EDT - June 24, 2021
Neal Rosen, MD, PhD, Memorial Sloan-Kettering Cancer Center
Track: Novel Therapeutics

Thursday
10:15am - 10:40am EDT - June 24, 2021
Alberto Bardelli, PhD, University of Torino
Track: Novel Therapeutics

Thursday
10:40am - 10:55am EDT - June 24, 2021
Radha Mukherjee, PhD, Memorial Sloan Kettering
Track: Novel Therapeutics

Thursday
10:55am - 11:10am EDT - June 24, 2021
Jordan Young, PhD, Repare Therapeutics, Canada
Track: Novel Therapeutics

11:35am - 12:25pm EDT - June 24, 2021
Klaus P. Hoeflich, PhD, Co-Chair, Nested Bio; Scott W. Lowe, PhD, Co-Chair, Memorial Sloan Kettering Cancer Center
Track: The Future of Precision Oncology

Thursday
11:35am - 12:00pm EDT - June 24, 2021
Elaine R. Mardis, PhD, Nationwide Children's Hospital
Track: The Future of Precision Oncology

Thursday
12:00pm - 12:25pm EDT - June 24, 2021
Naoko Takebe, MD, PhD, NCI, National Institutes of Health
Track: The Future of Precision Oncology

Thursday
12:25pm - 12:35pm EDT - June 24, 2021
Klaus P. Hoeflich, PhD, Organizer, Nested Bio; Scott W. Lowe, PhD, Organizer, Memorial Sloan Kettering Cancer Center